NovaBay Pharmaceuticals, Inc. (NBY) Appoints Mark M. Sieczkarek, Solta Medical, Inc. (SLTM) Chairman And CEO And Dr. Massimo Radaelli, Noventia Pharma CEO To Its Board Of Directors
1/9/2014 9:45:46 AM
EMERYVILLE, Calif., Jan. 9 2014 (GLOBE NEWSWIRE) -- NovaBay® Pharmaceuticals, Inc. (NYSE MKT:NBY), a clinical-stage biopharmaceutical company developing topical non-antibiotic antimicrobial products, has appointed Mark M. Sieczkarek and Dr. Massimo Radaelli to its Board of Directors.
Help employers find you! Check out all the jobs and post your resume.
comments powered by